Search Results - "Ruiz de Porras, V"

PO-447 CDK5 as a prognostic and predictive factor in colorectal cancer patients by Cabrero, S, Bystrup, S, Ruiz de Porras, V, Musulén, E, Subirats, JL, Queralt, C, Manzano, JL, Martinez-Balibrea, E

“…IntroductionCdk5 has been related to cancer progression and metastasis and to response to DNA damage in cancer. In colorectal cancer (CRC), our previous…”
Get full text

Differential gene expression profiles in poor vs good responders to maintenance vinflunine in patients (p) with advanced urothelial carcinoma (aUC): Preliminary results of biomarker analyses from the MAJA trial (SOGUG 2011/02) by Ramirez, J.L., Font Pous, A., Garcia-Donas, J., Perez Valderrama, B., Aguirre Egaña, I., Nonell, L., Ruiz de Porras Fontdevila, V., Mallo, M., Balañá, D., Virizuela, J.A., Anido, U., Llorente Ostiategui, M.M., Gonzalez del Alba Baamonde, M.A., Lainez, N., Mellado, B., Climent Duran, M.A., Bellmunt, J.

Get full text

Effect of selumetinib plus AZD8186 treatment on cabazitaxel sensitivity in docetaxel-acquired resistant metastatic prostate cancer cell lines by Ruiz de Porras, V., Laguía, F., Marín-Aguilera, M., Jiménez, N., Mellado, B., Ramirez, J.L., Martinez-Balibrea, E., Font, A.

Get full text

1950P - Effect of selumetinib plus AZD8186 treatment on cabazitaxel sensitivity in docetaxel-acquired resistant metastatic prostate cancer cell lines by Ruiz de Porras, V., Laguía, F., Marín-Aguilera, M., Jiménez, N., Mellado, B., Ramirez, J.L., Martinez-Balibrea, E., Font, A.

“…PI3K/AKT/mTOR and MEK/ERK signalling pathways act cooperatively to develop taxane resistance in metastatic castration resistant prostate cancer (mCRPC)…”
Get full text

1791P Molecular profiling and prognostic relevance of low PTEN expression in metastatic hormone-sensitive prostate cancer patients by Garcia De Herreros, M., Jimenez Blasco, N., Reig Torras, O., Ruiz de Porras, V., Pardo, J.C., Font Pous, A., Aversa, C., Ferrer-Mileo, L., Jorda, M., Rodríguez-Carunchio, L., Trias Puigsureda, I., Sánchez-Font, A., Rodriguez-Vida, A., Domenech Santasusana, M., Figols Gorina, M., Climent Duran, M.A., Chirivella Gonzalez, I., Herrero Rivera, D., Gonzalez Billalabeitia, E., Mellado Gonzalez, B.

Get full text

1950PEffect of selumetinib plus AZD8186 treatment on cabazitaxel sensitivity in docetaxel-acquired resistant metastatic prostate cancer cell lines by Ruiz de Porras, V, Laguía, F, Marín-Aguilera, M, Jiménez, N, Mellado, B, Ramirez, J L, Martinez-Balibrea, E, Font, A

“…Abstract Background PI3K/AKT/mTOR and MEK/ERK signalling pathways act cooperatively to develop taxane resistance in metastatic castration resistant prostate…”
Get full text

931P - Potential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based chemotherapy in muscle-invasive bladder cancer (MIBC) patients by Font, A., Domenech, M., Ramirez, J.L., Gago, J., Carrato, C., Cadenas, B., Benítez, R., Lobato, T., Pineda, S., Ruiz de Porras, V., Calle, M.L., Malats, N., Real, F.X.

“…Neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care in MIBC patients, although a limited survival benefit has been obtained compared…”
Get full text

Potential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based chemotherapy in muscle-invasive bladder cancer (MIBC) patients by Font, A., Domenech, M., Ramirez, J.L., Gago, J., Carrato, C., Cadenas, B., Benítez, R., Lobato, T., Pineda, S., Ruiz de Porras, V., Calle, M.L., Malats, N., Real, F.X.

Get full text

931PPotential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based chemotherapy in muscle-invasive bladder cancer (MIBC) patients by Font, A, Domenech, M, Ramirez, J L, Gago, J, Carrato, C, Cadenas, B, Benítez, R, Lobato, T, Pineda, S, Ruiz de Porras, V, Calle, M L, Malats, N, Real, F X

“…Abstract Background Neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care in MIBC patients, although a limited survival benefit has…”
Get full text

882 - Expression patterns and prognostic value of Cyclin-dependent kinase 5 (Cdk5) in colorectal tumours by de Porras, V. Ruiz, Cabrero-De las Heras, S., Bystrup, S., Subirats, J.L., Musulén, E., Manzano, J.L., Moreno, V., Layos, L., Bugés, C., Martinez-Balibrea, E.

Get full text

Expression patterns and prognostic value of Cyclin-dependent kinase 5 (Cdk5) in colorectal tumours by de Porras, V. Ruiz, Cabrero-De las Heras, S, Bystrup, S, Subirats, J.L, Musulén, E, Manzano, J.L, Moreno, V, Layos, L, Bugés, C, Martinez-Balibrea, E

Get full text

1001 CDK5 is Involved in Oxaliplatin Response and Resistance Acquisition Through Regulation of STAT3 Transcription Factor by de Porras, V. Ruiz, Alcon, C, Martinez-Cardús, A, Ginés, A, Musulén, E, Manzano, J.L, Abad, A, Martinez-Balibrea, E

Get full text

128PDifferential gene expression profiles in poor vs good responders to maintenance vinflunine in patients (p) with advanced urothelial carcinoma (aUC): Preliminary results of biomarker analyses from the MAJA trial (SOGUG 2011/02) by Ramirez, J L, Font Pous, A, Garcia-Donas, J, Perez Valderrama, B, Aguirre Egaña, I, Nonell, L, Ruiz de Porras Fontdevila, V, Mallo, M, Balañá, D, Virizuela, J A, Anido, U, Llorente Ostiategui, M M, Gonzalez del Alba Baamonde, M A, Lainez, N, Mellado, B, Climent Duran, M A, Bellmunt, J

Get full text

PP 78 Role of mucin3 gene in intrinsic resistance to oxaliplatin by Martínez-Cardús, A, Sureda, M, Ramírez, J.L, Ginés, A, de Porras, V. Ruíz, Bandrés, E, Malumbres, R, García-Foncillas, J, Abad, A, Martínez-Balibrea, E

Get full text